Moreover, this compound was able to repress the transactivation of CYP19 promoters I.3 and II in SK-BR-3 cells, which indicates that resveratrol could be able to reduce localized estrogen production in breast cancer cells [18]. The gene discussed is CYP19A1; the disease is breast cancer.